相关实验视频

Updated: Jul 15, 2025

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

Sam68是癌症干细胞中一种可用药物的脆弱点

Amanda Mendes da Silva¹, Veronika Yevdokimova¹, Yannick D Benoit^2,3

¹Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.

Cancer metastasis reviews

|October 4, 2023

概括

与68kDa (Sam68) 线粒分裂相关的Src对于癌症干细胞自我更新至关重要. 用新型药物向Sam68提供了一个有希望的策略来抑制瘤生长和发育.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

Sam68 (Src与68 kDa的线粒分裂相关) 是一种多功能蛋白质,参与RNA处理和信号传递.
最近的研究确定Sam68是抑制Wnt/β-catenin转录的药物的标.
这些药物通过参与Sam68.8.选择性地消除癌症干细胞 (CSC) 活动.

研究的目的:

讨论Sam68在瘤发生和癌症干细胞维护中的作用.
审查Sam68在CSCs必不可少的染色体调节中的参与.
为了探索CSC向药物发现的进展,我们专注于Sam68.

主要方法:

对Sam68在癌症中的功能进行文献综述.
分析Sam68在CSCs中的染色体调节中的作用.
对针对Sam68.8的药物发现工作的审查.

主要成果:

Sam68在维持瘤自我更新和瘤启动功能方面发挥着重要作用.
Sam68参与了对CSCs至关重要的染色体调节过程.
调节Sam68的细胞分布和相互作用是关键的治疗策略.

结论:

Sam68是癌症干细胞的一个关键漏洞.
向Sam68是一个有前途的治疗途径,可以抑制人类瘤中的瘤茎.
对Sam68向疗法的进一步研究可能会导致新的癌症治疗方法.

关键词:

美国中央银行 (CBP) 的CBP.癌症干细胞是癌症的干细胞.圣经中没有规范性.药物发现药物发现药物发现在SRC中,它是SRC.这就是Sam6868的原因.

更多相关视频

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

相关概念视频

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...